Life After STroke - the LAST Study

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT01467206
Collaborator
St. Olavs Hospital (Other), Asker & Baerum Hospital (Other), The Research Council of Norway (Other), Helse Midt-Norge (Other)
380
2
2
49
190
3.9

Study Details

Study Description

Brief Summary

The LAST study is a Norwegian multi site randomised controlled trial that intends to assess the effect of a long term follow up program after stroke. The program consists of a coordinating physiotherapist who will encourage and motivate included patients to perform at least 60 minutes of intensive motor training every week and 30 minutes of physical activity every day for 18 months after inclusion. The primary hypothesis is that patients receiving a long term follow up program after stroke will have better motor function at end of follow up than patients receiving standard care. A total of 390 home dwelling stroke patients living in the municipality of Trondheim, Asker and Bærum will be included at the out-patient clinic at St. Olavs Hospital or Bærum Hospital three months after their stroke. Included patients will be randomised to an intervention group receiving the long term follow up program or to a control group receiving standard care. Motor function, mental health and physical functioning in daily life will be assessed at inclusion and 18 months later. The LAST study is funded by the Norwegian Research Council, the Norwegian University of Science and Technology and the Central Norway Regional Health Authority and will conclude at the end of 2015.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Long term follow up by a coordinating physiotherapist
  • Behavioral: Standard care
N/A

Detailed Description

Supplement to the Life After Stroke - the LAST study ClinicalTrials.gov ID: NCT01467206

Changes in the planned statistical analysis, November 9, 2015 The original plan for statistical analysis was published in; Askim T, Langhammer B, Ihle-Hansen H, Magnussen J, Engstad T, Indredavik B. A Long-Term Follow-Up Programme for Maintenance of Motor Function after Stroke: Protocol of the life after Stroke-The LAST Study. Stroke Res Treat. 2012;2012:392101. doi: 10.1155/2012/392101. Epub 2012 Nov 22.

Original plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Mann-Whitney U test will be used for secondary data not being normal distributed. In all analyses we will control for potential confounding factors, investigate effect modifications, and present both unadjusted and adjusted effects with 95% confidence intervals.

Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site) to explore trends within subgroups of patients.

Revised plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Similar ANCOVA analyses will be used for the relevant secondary endpoints. Mann-Whitney U test will be used for secondary data not being normal distributed.

Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site), gender, and cognitive status (Mini Mental State below 25), to explore trends within subgroups of patients.

Missing values will be handled using single imputation (typically for items on instrument scales), or by multiple imputation, as appropriate.

Study Design

Study Type:
Interventional
Actual Enrollment :
380 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial
Actual Study Start Date :
Nov 1, 2011
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Long term follow up program

Behavioral: Long term follow up by a coordinating physiotherapist
Monthly meetings with an coordinating physiotherapist who motivate and encourage the patient to do 60 minutes of weekly exercise and 30 minutes of daily physical activity

Active Comparator: Standard care

Behavioral: Standard care
Standard care as it is given to all stoke patients after stroke

Outcome Measures

Primary Outcome Measures

  1. Motor Assessment Scale [18 months after inclusion]

    A measure of over all motor function

Secondary Outcome Measures

  1. Barthel Index [18 months follow up]

    A measure of activities of daily living

  2. Modified Rankin Scale [18 months follow up]

    A measure of dependency/independency

  3. Berg Balance Scale [18 months follow up]

    A measure of balance related to basic movement tasks

  4. Timed Up and Go [18 months follow up]

    A measure of balance related to transfer and walking

  5. Sit to stand test [18 months follow up]

    A measure of dynamic muscle strength according to a sit to stand task

  6. Six minute walk test [18 months follow up]

    A measure of endurance

  7. Stroke Impact Scale [18 months follow up]

    A measure of health related quality of life after stroke

  8. EuroQol 5D [18 months follow up]

    A simple measure of health related quality of life for the general population

  9. Fatigue Severity Scale [18 months follow up]

    A measure of the presence of fatigue

  10. One simple question on fatigue from the HUNT3 questionnaire [18 months follow up]

    A simple question used to assess tiredness in teh general Norwegian population

  11. Hospital Anxiety and Depression Scale [18 months follow up]

    A measure of anxiety and depression

  12. Mini Mental State Examination [18 months follow up]

    A measure of cognitive function

  13. Montreal Cognitive Assessment [18 months follow up]

    A measure of cognitive function related to vascular dementia

  14. falls [6, 12 and 18 months]

    Serious falls will be recorded from the patients hospital records

  15. Readmission to hospital [6, 12 and 18 months]

    Number of readmissions to hospital will be recorded from the patients medical records

  16. Death [6, 12 and 18 months]

    Information about death will be collected from the Norwegain Death Registry

  17. Fractures [6, 12 and 18 months]

    Information about fractures during follow up will be collected from the patients medical records

  18. Cardiovascular events [6, 12 and 18 months]

    Information about any cardiovascular events will be collected from the patients medical record

  19. Cerebrovascular events [6, 12 and 18 months]

    Information about any cerebrovascular events during follow up will be collected from teh patient's medical records

  20. International Physical Activity Questionnaire [6, 12 and 18 months]

    A measure of physical activity over the last week

  21. Physical activity assessed by ActivPAL sensor system [6, 12 and 18 months]

    A sensor system to assess the amount of physical activity during a 4-7 day period

  22. Three simple questions on physical activity from the HUNT questionnaire [18 months]

    A simple measure of physical activity

  23. Health costs [6, 12 and 18 months]

    Information about the use of health services will be collected by reviewing the patients' hospital records and records in primary health care system.

  24. National Institutes of Health Stroke Scale [18 months follow up]

    A measure of stroke severity

  25. Modified Ashworth Scale [18 months follow up]

    A measure to rate the degree of spasticity after stroke

  26. Gait speed [18 months follow up]

    A simple measure of maximum gait speed across a 10 metres distance

  27. Trailmaking test A and B [18 months follow up]

    A simple measure of executive cognitive function

  28. DS-14 [18 months follow up]

    A standard assessment of negative affectivity, social inhibition, and type D personality, which might be related to poor cardiovascular prognosis.

Other Outcome Measures

  1. VO2-peak [18 months follow up]

    VO2-peak is obtained by use of a symptom limited treadmill test to measure cardiovascular fitness. This measure is only used in the Trondheim arm of the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of stroke according to WHO's definition of stroke

  • Living in the city of Trondheim or the municipalities of Asker or Bærum

  • Included 2.5 - 4 months after stroke

  • Modified Rankin Scale 0 - 4

  • Living at home

  • Mini Mental State Examination > 20 or > 16 if aphasia

  • Provide informed consent

Exclusion Criteria:
  • Are already included in the study

  • Are included in other experimental studies

  • Unstable coronary function

  • Uncompensated heartfailure

  • Other diseases that make it difficult to complete the intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bærum Hospital Sandvika Norway
2 St. Olavs Hospital Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital
  • Asker & Baerum Hospital
  • The Research Council of Norway
  • Helse Midt-Norge

Investigators

  • Study Director: Bent Indredavik, Prof, National Taiwan Normal University
  • Principal Investigator: Torunn Askim, PhD, National Taiwan Normal University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01467206
Other Study ID Numbers:
  • 205309/H10
First Posted:
Nov 8, 2011
Last Update Posted:
Apr 13, 2020
Last Verified:
Apr 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2020